| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $5.67 | $4.90 | $5.35 | $5.70 | $5.81 | $1.11 | $0.96 | $1.10 |
| EPS (Diluted) | $5.64 | $4.88 | $5.33 | $5.67 | $5.76 | $1.10 | $0.95 | $1.09 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.4B | $16.2B | $15.7B | $15.8B | $16.8B | $15.0B | $12.6B | $11.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.5B | $0.3B | $0.2B | $2.1B | $1.2B | $0.3B | $0.3B |
| Total Liabilities | $14.4B | $14.4B | $14.0B | $14.4B | $15.1B | $13.4B | $11.0B | $10.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.9B | $1.8B | $1.7B | $1.5B | $1.7B | $1.7B | $1.6B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.3B | $0.2B | $0.3B | $0.1B | $0.1B | $0.0B |
| Investing Cash Flow | $-0.2B | $-0.4B | $0.2B | $-1.4B | $-1.0B | $-1.5B | $-0.1B | $-1.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.1B | $0.3B | $-0.4B | $-0.7B | $1.6B | $2.3B | $0.0B | $1.0B |